| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.29 | 8e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.004 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |